Evidence map›Paper›PMID 12485453›Full record

ArticleThe Journal of investigative dermatology2002

Expression of hypothalamic-pituitary-thyroid axis related genes in the human skin.

Andrzej Slominski, Jacobo Wortsman, Leonard Kohn, Kenneth B Ain, Gopalakrishnan M Venkataraman, Alexander Pisarchik, Jae Hoon Chung, Cesidio Giuliani, Mark Thornton, George Slugocki and 1 more

Open access · greenAbstract read
In one paragraph

Article in The Journal of investigative dermatology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 1 synthesis or guideline pooled it, 166 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Is Melanoma Progression Affected by Thyroid Diseases?International journal of molecular sciences · 2022
    Review
  19. Review
  20. Review

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Andrzej SlominskiDepartments of Pathology, and Surgery, University of Tennessee Health Science Center, Memphis, TN 38163, USA. aslominski@utmem.edu
Jacobo Wortsman
Leonard Kohn
Kenneth B Ain
Gopalakrishnan M Venkataraman
Alexander Pisarchik
Jae Hoon Chung
Cesidio Giuliani
Mark Thornton
George Slugocki
Desmond J Tobin
Ohio University · USUniversity of Tennessee Health Science Center · USAlbert B. Chandler Hospital · USSouthern Illinois University School of Medicine · USUniversity of Bradford · GB

Funding

Role of CRH in skin physiology and pathologyR01AR047079 · NIAMS · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI SLOMINSKI, ANDRZEJ T · 2002 to 2004
$708k
NIAMS NIH HHS AR047079-01A2NIAMS NIH HHS R01 AR047079
6 · The paper itself

Abstract

The skin is commonly affected in thyroid diseases, but the mechanism for this association is still unclear. As the skin expresses numerous neuroendocrine elements, we tested the additional cutaneous expression of mediators operating in the hypothalamic-pituitary-thyroid axis. We found significant expression of the thyroid-stimulating hormone receptor mRNA in cultured keratinocytes, epidermal melanocytes, and melanoma cells. The presence of thyroid-stimulating hormone receptor was confirmed by northern analyses and the thyroid-stimulating hormone receptor was found to be functionally active in cyclic adenosine monophosphate signal assays. Thyroid-stimulating hormone receptor expressing cells also expressed the sodium iodide symporter and thyroglobulin genes. We also found expression of deiodinases 2 and 3 (mainly deiodinase 2) in whole skin biopsy specimens, and in the majority of epidermal and dermal cells by reverse transcription-polymerase chain reaction followed by sequencing of the amplified gene segments. There was selective expression of the gene for thyroid-stimulating hormone beta; detection of the thyroid-releasing hormone gene was minimal and thyroid-releasing hormone receptor mRNA was not detected in most of the samples. Expression of functional thyroid-stimulating hormone receptor in the skin may have significant physiologic and pathologic consequences, particularly in autoimmune conditions associated with production of stimulating antibodies against the thyroid-stimulating hormone receptor. We conclude that the expanding list of neuroendocrine elements expressed in the skin supports a strong role for this system in cutaneous biology.

Indexed as

Skin Physiological PhenomenaAnimalsBasal Cell CarcinomaCell Line, TransformedCricetinaeGene ExpressionHumansHypothalamo-Hypophyseal SystemIodide PeroxidaseKeratinocytesMelanomaPituitary GlandReceptors, ThyrotropinReceptors, Thyrotropin-Releasing HormoneReverse Transcriptase Polymerase Chain ReactionSkinIodide PeroxidaseReceptors, ThyrotropinReceptors, Thyrotropin-Releasing HormoneSodium-Iodide SymportersSymportersThyroglobulinThyrotropinThyrotropin, beta SubunitThyrotropin-Releasing Hormone

Identifiers

PMID12485453
PMCPMC1201517
OpenAlexW2384428517

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.